Answers are grounded in this paper and cite their sources.
Cross-sectional study reveals high prevalence of MRSA and multidrug-resistant bacteria in sepsis cases, highlighting urgent need for action.
Background: Sepsis is a life-threatening condition with high mortality rates. The emergence of antimicrobial resistance (AMR) among pathogens that cause sepsis poses a significant challenge to effective treatment. This study was conducted to determine the AMR patterns of bacterial isolates from septic patients’ blood cultures with emphasis on extended-spectrum beta-lactamases (ESBLs), carbapenemase, and methicillin-resistant Staphylococcus aureus (MRSA) prevalence. Methods: This cross-sectional laboratory study examined blood culture samples of 1248 patients. The blood cultures were subcultured on MacConkey and chocolate agar media. Bacterial identification was based on gram-staining and biochemical tests. Initial and confirmatory antibiotic susceptibility testing was then performed according to CLSI 2022 for MRSA, vancomycin-resistant Enterococcus (VRE), and ESBLs. The statistical analysis of the study findings was conducted using SPSS. The accuracy level of the evaluations was determined with a 95% confidence interval. Results: Among the 174 cases of bloodstream infection (BSI) (13.9% positivity), Enterobacterales (59.8%) and gram-positive cocci (32.7%) were dominant isolates. Interestingly, the prevalence of MRSA was 67.5%, with a significantly higher prevalence in ICUs (81.3%; P=0.037). In gram-negative isolates, resistance to third-generation cephalosporins and carbapenems was 48.7% and 22.2%, respectively. Significant resistance to carbapenems (80%) was observed in Acinetobacter isolates, but all strains remained susceptible to colistin. ESBL producers included Escherichia coli (36.3%) and Klebsiella pneumoniae (16%). Notably, 52.4% of multidrug-resistant Enterobacteriaceae cases were isolated from patients in emergency departments and intensive care units. Conclusion: This study highlights the alarming prevalence of MDR bacteria among sepsis isolates. Precautions should be taken against this growing threat by focusing on three priorities: enhancing infection control, maintaining continuous surveillance, and exploring novel therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Deihim et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: